Exportar registro bibliográfico


Metrics:

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA) (2013)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021